Montelukast Sodium
Product Images NDC 60723-010

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 60723-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hangzhou Minsheng Binjiang Pharm, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1

A line graph showing change in height (cm) over weeks on treatment for Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo groups. The x-axis represents treatment duration from -19 to 56 weeks, and the y-axis displays height change from -3 to 7 cm. Each group is marked by different symbols and lines, illustrating comparative growth trends during treatment.*

FDA Label Image

Label (Label)

Montelukast Sodium Tablets 10 mg label showing dosage strength and packaging size of 30 tablets. The label specifies use for adults 15 years and older and states each tablet contains 10.4 mg montelukast sodium equivalent to 10 mg montelukast. Storage instructions and manufacturer information for Hangzhou Minsheng Binjiang Pharma are included. NDC 60723-010-03 is displayed with barcode.*

FDA Label Image

Image Of Montelukast Sodium Chemical Structure (Montelukast 02)

Chemical structure of Montelukast Sodium, showing its molecular arrangement including aromatic rings, chlorine, sulfur, and sodium carboxylate groups, consistent with the active ingredient in the labeled product.*

FDA Label Image

Image Of Figure 2 (Montelukast 03)

A line graph showing mean percent change from baseline over weeks of treatment comparing Montelukast Sodium and placebo. The x-axis represents weeks in treatment from 0 to 15, including a washout period after week 12. The y-axis represents mean percent change. Montelukast Sodium shows a higher increase compared to placebo over the treatment period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.